• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于知情者的工具对老年谵妄住院患者痴呆诊断的测试准确性:一项前瞻性队列研究。

Diagnostic test accuracy of informant-based tools to diagnose dementia in older hospital patients with delirium: a prospective cohort study.

作者信息

Jackson Thomas A, MacLullich Alasdair M J, Gladman John R F, Lord Janet M, Sheehan Bart

机构信息

Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK Centre for Translational Inflammation Research, Queen Elizabeth Hospital Mindelsohn Way, Birmingham B15 2WD, UK.

Delirium Research Group, Geriatric Medicine, University of Edinburgh, Edinburgh, UK Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK.

出版信息

Age Ageing. 2016 Jul;45(4):505-11. doi: 10.1093/ageing/afw065. Epub 2016 Apr 13.

DOI:10.1093/ageing/afw065
PMID:27076526
Abstract

BACKGROUND

delirium and dementia co-exist commonly in hospital. Older people with delirium have high rates of undiagnosed dementia, but delirium affects the use of cognitive testing in dementia diagnosis. Novel methods to detect dementia in delirium are needed. The purpose of the study was to investigate the diagnostic test accuracy of informant tools to detect dementia in hospitalised older people with delirium.

METHODS

the presence of dementia on admission was assessed using the short form of the Informant Questionnaire of Cognitive Decline in the Elderly (IQCODE-SF) and Alzheimer's Disease 8 (AD8) in people over 70 years old with delirium. Reference standard diagnosis was made using Diagnostic and Statistical Manual of Mental Disorders fourth edition (DSM-IV) criteria at 3 months. The main outcome measures were the diagnostic test accuracy of the IQCODE-SF and the AD8 in diagnosing DSM-IV dementia.

RESULTS

dementia prevalence at 3 months was 61%. The area under the receiver operating characteristic curve (AUROC) was 0.93 (P < 0.0005) for admission IQCODE-SF and 0.91 (P < 0.0005) for admission AD8. An IQCODE-SF test result of >3.82 on admission had a sensitivity of 0.91 (0.79-0.97) and specificity of 0.93 (0.76-0.99) for detecting dementia. An AD8 of >6 had a sensitivity of 0.83 (0.69-0.92) and specificity of 0.90 (0.72-0.97) for detecting dementia.

CONCLUSION

the IQCODE-SF and AD8 are sensitive and specific tools to detect prior dementia in older people with delirium. The routine use of either tool in practice could have important clinical impact, by improving the recognition and hence management of those with dementia.

摘要

背景

谵妄和痴呆在医院中常同时存在。患有谵妄的老年人未被诊断出痴呆的比例很高,但谵妄会影响痴呆诊断中认知测试的应用。需要新的方法来在谵妄患者中检测痴呆。本研究的目的是调查 informant 工具在住院的谵妄老年患者中检测痴呆的诊断测试准确性。

方法

使用老年认知功能减退知情者问卷简表(IQCODE-SF)和阿尔茨海默病 8 项问卷(AD8)评估 70 岁以上谵妄患者入院时是否存在痴呆。采用《精神障碍诊断与统计手册》第四版(DSM-IV)标准在 3 个月时进行参考标准诊断。主要结局指标是 IQCODE-SF 和 AD8 在诊断 DSM-IV 痴呆方面的诊断测试准确性。

结果

3 个月时痴呆患病率为 61%。入院时 IQCODE-SF 的受试者工作特征曲线下面积(AUROC)为 0.93(P < 0.0005),入院时 AD8 的 AUROC 为 0.91(P < 0.0005)。入院时 IQCODE-SF 测试结果>3.82 检测痴呆的敏感性为 0.91(0.79 - 0.97),特异性为 0.93(0.76 - 0.99)。AD8>6 检测痴呆的敏感性为 0.83(0.69 - 0.92),特异性为 0.90(0.72 - 0.97)。

结论

IQCODE-SF 和 AD8 是检测谵妄老年患者既往痴呆的敏感且特异的工具。在实践中常规使用这两种工具中的任何一种都可能通过改善对痴呆患者的识别从而改善其管理,产生重要的临床影响。

相似文献

1
Diagnostic test accuracy of informant-based tools to diagnose dementia in older hospital patients with delirium: a prospective cohort study.基于知情者的工具对老年谵妄住院患者痴呆诊断的测试准确性:一项前瞻性队列研究。
Age Ageing. 2016 Jul;45(4):505-11. doi: 10.1093/ageing/afw065. Epub 2016 Apr 13.
2
Undiagnosed long-term cognitive impairment in acutely hospitalised older medical patients with delirium: a prospective cohort study.急性住院的老年内科谵妄患者中未诊断出的长期认知障碍:一项前瞻性队列研究。
Age Ageing. 2016 Jul;45(4):493-9. doi: 10.1093/ageing/afw064. Epub 2016 Apr 13.
3
Comparative validity of informant tools for assessing pre-stroke cognitive impairment.用于评估卒中前认知障碍的知情者工具的比较有效性。
Int J Geriatr Psychiatry. 2022 Apr;37(4). doi: 10.1002/gps.5700.
4
Validation of the 6-Item Cognitive Impairment Test and the 4AT test for combined delirium and dementia screening in older Emergency Department attendees.验证 6 项认知障碍测试和 4AT 测试在老年急诊科就诊者中联合用于谵妄和痴呆筛查的有效性。
Age Ageing. 2018 Jan 1;47(1):61-68. doi: 10.1093/ageing/afx149.
5
Comparison of 2 informant questionnaire screening tools for dementia and mild cognitive impairment: AD8 and IQCODE.两种用于痴呆症和轻度认知障碍筛查的知情者问卷筛查工具比较:AD8 和 IQCODE。
Alzheimer Dis Assoc Disord. 2014 Apr-Jun;28(2):156-61. doi: 10.1097/WAD.0000000000000008.
6
Validation of the 4AT, a new instrument for rapid delirium screening: a study in 234 hospitalised older people.新型谵妄快速筛查工具4AT的验证:对234名住院老年人的研究
Age Ageing. 2014 Jul;43(4):496-502. doi: 10.1093/ageing/afu021. Epub 2014 Mar 2.
7
Validating the 4A's test in screening for delirium in a culturally diverse geriatric inpatient population.验证 4A's 测试在文化多元化老年住院患者人群中筛查谵妄的有效性。
Int J Geriatr Psychiatry. 2017 Dec;32(12):1322-1329. doi: 10.1002/gps.4615. Epub 2016 Oct 20.
8
Diagnostic utility of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) and its combination with the Addenbrooke's Cognitive Examination-Revised (ACE-R) in a memory clinic-based population.老年人认知功能减退知情者问卷(IQCODE)及其与修订版Addenbrooke认知检查(ACE-R)联合在记忆门诊人群中的诊断效用。
Int Psychogeriatr. 2009 Jun;21(3):526-30. doi: 10.1017/S1041610209008941. Epub 2009 Mar 30.
9
Evaluation of delirium screening tools in geriatric medical inpatients: a diagnostic test accuracy study.老年内科住院患者谵妄筛查工具的评估:一项诊断试验准确性研究。
Age Ageing. 2016 Nov;45(6):832-837. doi: 10.1093/ageing/afw130. Epub 2016 Aug 8.
10
Informant single screening questions for delirium and dementia in acute care--a cross-sectional test accuracy pilot study.急性护理中谵妄和痴呆的 informant 单一筛查问题——一项横断面测试准确性的试点研究。
BMC Geriatr. 2015 Feb 25;15:17. doi: 10.1186/s12877-015-0016-1.

引用本文的文献

1
Validation of the 4AT for assessing recovery from delirium in older hospital patients.用于评估老年住院患者谵妄恢复情况的4AT评估工具的验证
Age Ageing. 2025 May 31;54(6). doi: 10.1093/ageing/afaf166.
2
Pulling Back the Curtain on Hospital Dementia Detection: Validation of the Informant-Based Clinical Dementia Rating.揭开医院痴呆症检测的面纱:基于 informant 的临床痴呆评定量表的验证
J Am Geriatr Soc. 2025 Aug;73(8):2524-2530. doi: 10.1111/jgs.19494. Epub 2025 May 2.
3
Differences in metalloproteinases and their tissue inhibitors in the cerebrospinal fluid are associated with delirium.
脑脊液中金属蛋白酶及其组织抑制剂的差异与谵妄有关。
Commun Med (Lond). 2024 Jun 27;4(1):124. doi: 10.1038/s43856-024-00558-z.
4
Diagnostic accuracy of Ascertain Dementia 8-item Questionnaire by participant and informant-A systematic review and meta-analysis.参与者和知情人评估的 Ascertain Dementia 8 项问卷的诊断准确性:系统评价和荟萃分析。
PLoS One. 2023 Sep 12;18(9):e0291291. doi: 10.1371/journal.pone.0291291. eCollection 2023.
5
Impaired glucose utilization in the brain of patients with delirium following hip fracture.髋部骨折后谵妄患者的大脑葡萄糖利用受损。
Brain. 2024 Jan 4;147(1):215-223. doi: 10.1093/brain/awad296.
6
Dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care.两阶段认知评估:初级保健中认知障碍的两阶段筛查。
BMC Psychiatry. 2023 May 25;23(1):368. doi: 10.1186/s12888-023-04883-w.
7
Development of a UK core dataset for geriatric medicine research: a position statement and results from a Delphi consensus process.开发英国老年医学研究核心数据集:德尔菲共识过程的立场声明和结果。
BMC Geriatr. 2023 Mar 23;23(1):168. doi: 10.1186/s12877-023-03805-5.
8
Cerebrospinal fluid quinolinic acid is strongly associated with delirium and mortality in hip-fracture patients.脑脊髓液喹啉酸与髋部骨折患者的谵妄和死亡率密切相关。
J Clin Invest. 2023 Jan 17;133(2):e163472. doi: 10.1172/JCI163472.
9
Comparison of delirium detection tools in acute care : A rapid review.急性护理中谵妄检测工具的比较:快速综述。
Z Gerontol Geriatr. 2022 Mar;55(2):105-115. doi: 10.1007/s00391-021-02003-5. Epub 2022 Jan 14.
10
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early detection of dementia across a variety of healthcare settings.用于在各种医疗保健环境中早期发现痴呆症的老年人认知减退信息问卷 (IQCODE)。
Cochrane Database Syst Rev. 2021 Jul 18;7(7):CD011333. doi: 10.1002/14651858.CD011333.pub3.